pelin
@absint
Şu anda okuduğu kitaplar
The key to the chronic disease kingdom is that there are not four separate problems (nutrition, metabolism, inflammation, immunity); there's only one, and they are all related. Screw up one and you screw up the other three.
Reklam
Pharma grew in the 1950s because of the success of antibiotics that poison the cellular pathways of bacteria (which are like plant cells) without poisoning other necessary animal cell pathways. This is why they've been effective in eradicating most acute infectious diseases.
But when we're dealing with chronic conditions, the dysfunctional pathway is the human's energy metabolic pathways (not the bacteria's), primarily our mitochondria. But there's no medicine that can get to and fix the mitochondria. In fact, treating with antibiotics for acute infectious diseases may have altered the bacteria in our gut so severely that new and resistant bacteria have moved in to take their place.
A meta-analysis by the Cochrane institute demonstrates that when the same drug is evaluated in two studies -one sponsored by Big Pharma and one independently- though the results are similar, the conclusions drawn are completely different. The industry reports were less transparent, had few reservations about methodological limitations, and had more favorable conclusions than the independent studies.
Between 2000 and 2008, a total of 667 drugs were approved by the FDA, yet only 11 percent of them were deemed truly innovative; the rest were knockoff analogs in an attempt to way onto the market.
Every single drug company spends more on marketing than on research and development.
Reklam